Streetbeat News

Analyst Ratings

TSX:GRT

BMO Capital analyst Joanne Chen has maintained an 'Outperform' rating on Granite REIT, but lowered the price target from C$98 to C$91.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 12:46 pm

HPP

Goldman Sachs analyst Caitlin Burrows maintains a 'Sell' rating on Hudson Pacific Properties (NYSE:HPP) and raises the price target from $4 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:45 pm

DECK

TD Cowen analyst John Kernan maintains an Outperform rating on Deckers Outdoor (NYSE:DECK) and raises the price target from $564 to $618.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 12:45 pm

CNTA

Goldman Sachs analyst Salveen Richter maintains a Neutral rating on Centessa Pharmaceuticals (NASDAQ:CNTA) and raises the price target from $4.5 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:44 pm

BTAI

Goldman Sachs analyst Corinne Jenkins has maintained a Neutral rating on BioXcel Therapeutics (NASDAQ:BTAI) and lowered the price target from $12 to $4.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:43 pm

MNDY

TD Cowen analyst J. Derrick Wood maintains an Outperform rating on Monday.Com (NASDAQ:MNDY) and raises the price target from $215 to $220.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 12:43 pm

AGL

Goldman Sachs analyst Jamie Perse maintains a Buy rating on Agilon Health (NYSE:AGL) but lowers the price target from $29 to $25.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:42 pm

CHPT

TD Cowen analyst Gabe Daoud maintains an Outperform rating on ChargePoint Hldgs (NYSE:CHPT) but lowers the price target from $20 to $14.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 12:41 pm

TSVT

Goldman Sachs analyst Salveen Richter maintains a Buy rating on 2seventy bio (NASDAQ:TSVT) but lowers the price target from $27 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:41 pm

NVDA

Wells Fargo analyst Aaron Rakers has maintained an Overweight rating on NVIDIA and raised the price target from $450 to $500.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:39 pm